CAPTOPRIL IN HYPERTENSION - 7 YEARS LATER

[1] [Anonymous], 1981, LANCET, V2, P539

[2] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J]. HYPERTENSION, 1979, 1 (01) : 39 - 46

[3] SEVERE REVERSIBLE AZOTEMIA FROM CAPTOPRIL THERAPY - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE [J]. ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) : 437 - 441

[4] CAPTOPRIL-ASSOCIATED NEUTROPENIA - WHO IS AT RISK [J]. ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (04) : 659 - 660

[5] DOMBEY S, 1983, LANCET, V1, P529

[6] DRURY PL, 1982, NEW ENGL J MED, V307, P58

[7] DZAU VJ, 1983, KIDNEY INT, V23, P121

[8] FERGUSON RK, 1977, LANCET, V1, P775

[9] GAVRAS H, 1978, NEW ENGL J MED, V299, P363

[10] GROEL JT, 1983, HYPERTENSION, V5, P145

[1] [Anonymous], 1981, LANCET, V2, P539

[2] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J]. HYPERTENSION, 1979, 1 (01) : 39 - 46

[3] SEVERE REVERSIBLE AZOTEMIA FROM CAPTOPRIL THERAPY - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE [J]. ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) : 437 - 441

[4] CAPTOPRIL-ASSOCIATED NEUTROPENIA - WHO IS AT RISK [J]. ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (04) : 659 - 660

[5] DOMBEY S, 1983, LANCET, V1, P529

[6] DRURY PL, 1982, NEW ENGL J MED, V307, P58

[7] DZAU VJ, 1983, KIDNEY INT, V23, P121

[8] FERGUSON RK, 1977, LANCET, V1, P775

[9] GAVRAS H, 1978, NEW ENGL J MED, V299, P363

[10] GROEL JT, 1983, HYPERTENSION, V5, P145